Leishmania donovani p36(LACK) DNA Vaccine Is Highly Immunogenic but Not Protective against Experimental Visceral Leishmaniasis

The acquisition of immunity following subclinical or resolved infection with the intracellular parasite Leishmania donovani suggests that vaccination could prevent visceral leishmaniasis (VL). The LACK (Leishmania homolog of receptors for activated C kinase) antigen is of interest as a vaccine candi...

Full description

Saved in:
Bibliographic Details
Main Authors: Melby, Peter C., Yang, Jue, Zhao, Weiguo, Perez, Luis E., Cheng, Jun
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2001
Subjects:
Microbial Immunity and Vaccines
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC98557/
https://ncbi.nlm.nih.gov/pubmed/11447143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.69.8.4719-4725.2001
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items